Nexira Group has acquired Tournay Biotechnologies, a European extractor of active botanicals for the nutraceutical and dietary supplements industries. The acquisition enables Nexira to expand its range of ingredients and reinforce its positioning toward the health and wellness market, which will soon represent 35% of its commercial activity. Nexira’s growth target is €125 million in consolidated sales by 2015. Tournay Biotechnologies, a family owned company founded in 1992, produces extracts including cranberry, green coffee and green tea. The company has an ISO 22000 certified and state-of-the-art manufacturing facility located near Bordeaux, France, responsible for an extensive product portfolio including its flagship brand Exocyan, a line of cranberry extracts standardized on proanthocyanidins (PACs) content. PACs are condensed tannins, a type of flavonoid, with antioxidant and other health activities.